Sentences with phrase «of cholangiocarcinoma»

Risk Factors for Cholangiocarcinoma: Aspirin - use and the Risk of Cholangiocarcinoma, Hepatology (2016).

Professor Tan added, «This work builds on our earlier work to complete the picture of host and pathogen genetics of cholangiocarcinoma [3].

Not exact matches

A patients» tumors from cholangiocarcinoma, a rare liver cancer that typically fails chemotherapy, shrunk significantly after treatment with FGFR inhibitors, which were prescribed based on results of next generation sequencing.

«In 3 out of the 6 patients we analyzed, we found compelling, treatable and unexpected genetic alterations that would never have been found by normal testing methods for cholangiocarcinoma,» says Mitesh Borad, M.D., a Mayo Clinic oncologist and lead author of the paper.

Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to a research published in the July issue of the journal Nature.

«We now hope to design larger clinical studies to treat patients» tumors harboring these novel genomic aberrations to further explore the precise extent of clinical benefit for patients with primary or advanced cholangiocarcinoma.»

A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma.

The parasites can cause cholangiocarcinoma, a highly lethal bile duct cancer that is rare in the Western world but nearly 50 times more common (85 cases per 10,000 people) in Northeast Thailand, a hotspot of liver fluke infestation.

«A VEGF cut of value of 0.5 ng / mL distinguished pancreatic cancer from cholangiocarcinoma and this measure is both 93 percent sensitive and 89 percent specific,» reported Udayakumar Navaneethan, M.D. of the Cleveland Clinic Foundation.

A Phase 3, Multicenter, Randomized, Double - Blind, Placebo - Controlled Study of AG - 120 in Previously - Treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation

Upregulation of retinoic acid receptor - ß reverses drug resistance in cholangiocarcinoma cells by enhancing susceptibility to apoptosis.

Adenocarcinoma of the Appendix, Anal cancer, Breast Cancer, Cancer, Squamous cell carcinoma, Colorectal Cancer, Esophageal Cancer, Esthesioneuroblastoma, Hodgkin lymphoma, Intrahepatic cholangiocarcinoma, Laryngeal cancer, Lip and oral cavity cancer, Liposarcoma, Liver cancer, Multiple myeloma, Nasopharyngeal carcinoma, Non-small cell lung cancer, Oral cancer, Osteosarcoma, Pancreatic cancer, Rectal Cancer, Salivary Gland Cancer, Stomach cancer, Synovial sarcoma, Testicular cancer, Tongue cancer, Vaginal cancer, Bladder cancer, Cervical cancer, Prostate cancer, Non-Hodgkin lymphoma, Brain Cancer, Thyroid Cancer, Ewing Sarcoma, Extrahepatic bile duct cancer, Melanoma

A Randomized Phase 2 Study of Atezolizumab in Combination with Cobimetinib Versus Atezolizumab Monotherapy in Participants with Unresectable Cholangiocarcinoma

A Pivotal Trial of ARQ 087 in Subjects with FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

A board - certified general surgeon and surgical oncologist, Kevin Roggin, MD, specializes in the surgical treatment of complex upper gastrointestinal tract and hepato - pancreato - biliary (HPB) cancers (stomach, pancreas, liver, gallbladder, gastrointestinal stromal tumors (GIST), sarcomas, extrahepatic bile duct cholangiocarcinoma).

An Open - Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B - 6527 in Subjects with Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

University of Cincinnati Cancer Institute transplant surgeons are offering a unique procedure to remove inoperable, cancerous tumors from the bile duct of the liver, known as cholangiocarcinoma, potentially improving survival...

Incidences of intrahepatic cholangiocarcinoma (ICC) are happening more often, with patients facing low chances of surviving the disease using current treatments - this can be as low as five per cent survival rate 12 months after diagnosis.

The majority of other cancers arise from cells of the bile ducts and include cholangiocarcinoma.

Dr. Azad's clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma / pancreaticobiliary tract cancer.

Treatment of pancreas, liver, and gastrointestinal tract diseases; treatment of adrenal, bile duct (cholangiocarcinoma), colon / colorectal, gallbladder, gastrointestinal, liver, sarcoma, and stomach cancers

Studies show that curcumin inhibits different types of cancer such as hepatocellular carcinoma and cholangiocarcinoma by influencing these signalling proteins.

Cholangiomas and cholangiocarcinomas are rare in both dogs and cats but less rare in cats and most such cases occur in cats over ten years of age.

Cholangiocarcinoma is a cancerous growth in one of the ducts that carries bile from the liver to the small intestine.